Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen's latest drug may be costly, but new data suggests it saves lives
Biogen's latest drug may be costly, but new data suggests it saves lives
Biogen's latest drug may be costly, but new data suggests it saves lives
Submitted by
admin
on January 14, 2017 - 3:37pm
Source:
Bizjournals.com
News Tags:
Biogen
Spinraza
SMA
spinal muscular atrophy
Headline:
Biogen's latest drug may be costly, but new data suggests it saves lives
Do Not Allow Advertisers to Use My Personal information
